Activating Immunity to Fight a Foe - A New Path

N Engl J Med. 2020 Mar 26;382(13):1270-1272. doi: 10.1056/NEJMcibr1917242.

Authors

Richard S Hotchkiss¹, Steven M Opal¹

Affiliation

¹ From the Departments of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine, St. Louis (R.S.H.); and the Department of Medicine, Alpert Medical School of Brown University, Providence, RI (S.M.O.).

No abstract available

MeSH terms

Adjuvants, Immunologic / therapeutic use
Anti-Infective Agents / therapeutic use*
CD4-Positive T-Lymphocytes
Combined Modality Therapy
Humans
Immunotherapy*
Infections / drug therapy
Infections / immunology
Infections / therapy*

Substances

Adjuvants, Immunologic
Anti-Infective Agents

Grants and funding

R35 GM126928/GM/NIGMS NIH HHS/United States